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Abstract Cerebral perfusion-weighted imaging (PWI) in
neonates is known to be technically difficult and there are
very few published studies on its use in preterm infants. In this
paper, we describe one convenient method to perform PWI in
neonates, a method only recently used in newborns. A device
was used to manually inject gadolinium contrast material
intravenously in an easy, quick and reproducible way. We
studied 28 newborn infants, with various gestational ages and
weights, including both normal infants and those suffering
from different brain pathologies. A signal intensity–time
curve was obtained for each infant, allowing us to build
perfusion maps. This technique offered a fast and easymethod
tomanually inject a bolus gadolinium contrast material, which
is essential in performing PWI in neonates. Cerebral PWI is
technically feasible and reproducible in neonates of various
gestational age and with various pathologies.
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Introduction
Cerebral perfusion-weighted imaging (PWI) is known to be
a minimally invasive technique and provides data at a
relatively high resolution allowing direct comparison of the
perfusion of different structures within the brain [1]. Many
studies on cerebral PWI have been performed in adults using
dynamic-susceptibility contrast-enhanced (DSCE) gradient-
echo MRI. The noninvasive character of PWI, the suscep-
tibility for microvascular haemodynamic alterations, the
short acquisition times, the lack of ionizing radiation and
the present widespread availability of MRI scanners make
PWI ideally suited to children. However, cerebral PWI has
only recently been used in newborns and there are very few
published studies using PWI in the very immature brain
[1, 2]. The main technical difficulties are the small head size
of newborns, fast heart rate, motion artefacts and the small
quantity of contrast material to be injected.
Intravenous (IV) infusion of contrast material is known to
have risks, such as contrast material extravasation into the
soft tissue surrounding the injection site. To obtain cerebral
PWI with good quality images an adequate quantity of
contrast material injected at a high flow rate is mandatory.
The use of power injectors has been associated with higher
rates of extravasation than manual injections [3].
We describe here a manual, simple and reproducible
technique for IV infusion of gadolinium contrast material
for cerebral PWI. We also sought to determine whether
PWI is technically feasible in neonates of various gesta-
tional ages, weights and pathologies.
Technique
A prospective study of 28 newborn infants was performed
over a period of 2 years (October 2005 to June 2007). Cerebral
PWI was added in all infants who underwent a MRI study
(conventional MRI, diffusion-weighted imaging and PWI) as
part of a detailed clinical neurological evaluation. Parental
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consent was obtained for all injections of gadolinium.
Diuresis, serum urea and creatinine levels were available for
all patients. The local ethics committee approved the study
protocol. The inclusion criterion was an agreed conventional
MRI scan as part of a detailed clinical neurological evaluation.
The exclusion criteria were impaired renal function, oliguria
and infants too unstable for transport to the MRI scanner.
The MRI study was obtained when the patients were
stable for transport to the MRI scanner. Newborn infants
were wrapped in a pillow containing polystyrene balls.
Blankets were wrapped around the infant and the pillow,
keeping the infant warm during scanning. Ear muffs were
used to reduce the effects of gradient-generated noise. No
sedation was used except in a single patient with hypoxic-
ischaemic encephalopathy who manifested a seizure during
the MRI scan necessitating IV injection of benzodiazepine.
MRI was performed using a 1.5-T machine (Symphony,
Siemens, Erlangen, Germany). Dynamic, T2*, perfusion,
gradient-echo EPI images were acquired (TR/TE 1,220/
54 ms) during the injection. Twelve axial sections (slice
thickness 5 mm; interslice gap 0.5 mm; field of view 230 mm;
matrix size 128×128) were imaged 40 times every 1.26 s.
After approximately 15 baseline images had been acquired, an
IV bolus of 0.2 ml/kg of gadolinium contrast material at a dose
of 0.1 mmol/kg (Omniscan; GE Healthcare Bio-Sciences,
Little Chalfont, UK), released by the manufacturer for use in
newborns at the time of the study, was manually injected. Our
device is composed of the following components: one needle
(19 gauge; Terumo Medical Corporation, Somerset, NJ), one
1-ml syringe, one 5-ml syringe, a 3-ml tube extension, and
normal saline (Fig. 1). The device is assembled by connect-
ing the 5-ml syringe to the 3-ml tube extension with a
Fig. 1 Equipment and assem-
bly. a Materials: from left to
right one needle, one 1-ml sy-
ringe, one 5-ml syringe, two
stopcocks, 3-ml extension tub-
ing, and saline. b Assembly: the
5-ml syringe connected to the 3-
ml extension tubing with a
stopcock at each end and filled
with saline. c Filling with
0.1 mmol/kg of gadolinium
contrast material. d Ready to be
connected to the patient. e
Ready to perform injection
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stopcock at each end (Fig. 1). The tube extension is then
flushed with normal saline. The tube is slowly filled with
0.1 mmol/kg of gadolinium contrast material from the other
end by the 1-ml syringe and normal saline is withdrawn at
the same time into the 5-ml syringe so that the contrast lies in
contact with normal saline as demonstrated in Fig. 1. The
device is then connected to the venous line of the patient in
readiness to perform the bolus injection (Fig. 1). The venous
line was a 24- or 26-gauge catheter placed in the dorsum of
the hand or in the antecubital fossa.
Complete imaging and data were available for 28 studies
in 25 nonsedated newborn infants with a mean gestational
age of 39 weeks (range 31–42 weeks) and a mean weight of
2,902 g (range 815–4,000 g). Nine of the 28 studies were
normal. Brain pathologies were hypoxic-ischaemic enceph-
alopathy (n=8), stroke (n=2), intracerebral haemorrhage
(n=6), congenital infection (n=2), and hemimegalencephaly
(n=1). No significant motion artefacts were present.
A signal intensity–time curve was obtained for each
patient, permitting us to build perfusion maps. Qualitative
perfusionmapswere obtained using General Electric Functool
Software 2.6.8 (GE Medical System, Milwaukee, WI). The
maximum slope of decrease and negative enhancement
integral were used as qualitative relative cerebral blood flow
(rCBF) and relative cerebral blood volume (rCBV) maps.
The arterial input function (AIF) for each patient was
obtained by manual selection of pixels in the neighbourhood
of the middle cerebral artery or internal carotid artery. The
rCBF was obtained as the maximum value of the residue
function obtained by SVD (singular value decomposition).
The rCBVwas obtained by integrating the concentration–time
curves between selected time points used (typically
corresponding to the arrival of contrast agent in the region of
interest and the end of the first pass).
The perfusion maps obtained displayed perfusion varia-
tions in the different normal brain regions, such as the
Fig. 2 Normal perfusion in a term newborn infant. a rCBV map
reveals symmetrical perfusion of both cerebral hemispheres. Note the
physiological distribution of greater blood volume in the basal
ganglia. b The concentration–time curve can be used to evaluate
relative blood volume. Note the greatest blood volume (purple curve)
found in the cortical mantle compared to the lower blood volume
(green curve), as expected, in the white matter region
Fig. 3 Concentration–time curve in a voxel within the left internal
carotid artery used as an arterial input function. The curve shows the
sharp decline in signal intensity on contrast medium arrival and the
sharp increase with wash-out of the contrast medium. The signal
intensity remains slightly lower than the initial baseline signal
intensity due to residual circulating contrast agent
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physiologically increased perfusion in the basal ganglia and
cortex compared to white matter (Fig. 2). They also
displayed the perfusion abnormalities associated with
several brain pathologies affecting newborns.
Discussion
Abnormalities of cerebral perfusion are believed to be of
prime importance in a number of basic pathologies
associated with the neonatal and infant brain. Perfusion-
weighted MRI is technically feasible and reproducible in
neonates of various gestational ages and pathologies. It
involves the administration of gadolinium, but is otherwise
noninvasive and could, therefore, be easily included as part
of a clinically indicated MRI scan.
To perform cerebral PWI the fast and safe injection of an
IV bolus of gadolinium contrast material is essential. Many
methods of IV injection of contrast material have been
described. Automated power injectors were developed for
injection of contrast material through peripheral venous
catheters at specific flow rates. However, their most
important complication is the risk of extravasation of
contrast material. This risk is more important in children
than adults [4]. The use of power injectors in the imaging of
children is, therefore, avoided in some institutions. Powel et
al. [5] described a new device (extravasation detection
accessory) to limit extravasation during contrast-enhanced
CT studies performed with power injectors. Other tradi-
tional manual or drip injection methods may not provide
optimum flow rates, and peak levels of organ enhancement
may not always be achieved [6].
Our device permits the manual injection of gadolinium
in an easy, quick and reproducible manner. It does not
require additional larger access for bolus delivery than
those already in place in a newborn coming for an MRI
study. In all our cases filling of the tube with gadolinium
was performed at the beginning of the examination and
hooked up to the patient at the beginning of the MRI study.
Thus we did not have to move the patient during the MRI
examination. The 3-ml extension tubing was filled very
slowly with gadolinium in order to avoid mixing of normal
saline and gadolinium.
Some degree of contrast dilution is inevitable. Never-
theless, thanks to the small volume of the extension tubing
(3 ml) and the stopcock at each end, the dilution of
gadolinium is very limited. For example, a 3-kg child
needing 0.6 ml of contrast medium has that contrast
medium dose diluted only by a factor of 5. Therefore, the
limited dilution allows a short enough bolus injection for
adequate perfusion data acquisition. It allows fast injection
of contrast material flushed by 5 ml of normal saline,
permitting a sharp bolus profile that enables the generation
of accurate rCBF, rCBV and transit time PWI maps (Figs. 2
and 3). In a recent study, Wintermark et al. [7] used the
same device to perform cerebral PWI for the evaluation of
the temporal evolution of neonatal hypoxic-ischaemic
encephalopathy in two newborn infants and three control
infants.
In our series, the quality of bolus IV injection of
gadolinium contrast material allowed correct diagnoses in
all patients with pathology and the realization of qualitative
perfusion maps in all patients. Comparing the three normal
patients who were examined using MRI scans including
PWI, values of CBF in the different regions of interest were
similar. Furthermore, in four patients with hypoxic-ischae-
mic encephalopathy MRI scans including PWI were
repeated early and late after birth. Values of perfusion in
the cerebral regions where there were no hypoxic-ischaemic
lesions were similar between the early and late scans.
The obtained perfusion maps in all of our patients
displayed sufficient resolution to detect perfusion differ-
ences in the different normal brain regions and also to
detect perfusion abnormalities in newborns with patholo-
gies involving brain vessels.
Recent warnings suggest that gadolinium contrast agent
should be used cautiously in patients with renal function
disturbance. It is therefore imperative that paediatric
practitioners are prudent and immediately tighten their
local policies on the use of IV gadolinium-based contrast
agents [8]. The manufacturers have extended these precau-
tions to neonates in view of their immature renal function.
It is important to state that all our patients were studied
before these warnings were issued. Nevertheless, no early
or late adverse effects have been documented so far.
In conclusion, we demonstrated that this method for the
manual injection of contrast medium is easy, quick and
safe, and allows reproducible PWI maps to be obtained in
the neonatal age group. Further studies with increased
numbers of patients will bring more information about
normal values of brain perfusion in newborn infants.
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